As a further demonstration of the reliability of our findings, we created subcutaneous xenograft models and demonstrated that the TGF-β1/FAP/VCAN axis regulates bladder cancer EMT in vivo (Fig. 8; Additional file 9). This evidence concerns the gene TGFB1 and urinary bladder carcinoma.